Sinew Pharma Inc. (TPEX:6634)
Taiwan · Delayed Price · Currency is TWD 53.50
+1.80 (3.48%)
Sep 8, 2026, 12:18 PM CST
Sinew Pharma Revenue
Sinew Pharma had revenue of 47.00K TWD in the twelve months ending June 30, 2026. In the year 2025, Sinew Pharma had annual revenue of 47.00K.
Revenue
47.00K
Revenue Growth
n/a
P/S Ratio
78,446.38
Revenue / Employee
903.85
Employees
52
Market Cap
3.69B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 47.00K | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | 328.00K | -5.90M | -94.73% |
| Dec 31, 2021 | 6.23M | 5.77M | 1,248.27% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Apex Biotechnology | 1.87B |
| SYN-TECH Chem. & Pharm. | 1.27B |
| Sagittarius Life Science | 467.69M |
| BioGend Therapeutics | 236.58M |
| Pharmosa Biopharm | 53.38M |
| Formosa Pharmaceuticals | 52.59M |
| OBI Pharma | 52.20M |
| Shine-On BioMedical | 50.62M |